Delving into the Latest Updates on Xiamen Zixu Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Endocrinology and Metabolic Disease

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

VDR(Vitamin D receptor)	1

Primary study objective: To evaluate the safety and tolerability of a single fasting oral dose of vitamin D oral solution in vitamin D-deficient individuals. Secondary study objective: To evaluate the pharmacokinetic profile of a single fasting oral dose of vitamin D oral solution in vitamin D-deficient individuals.

Start Date23 Dec 2025

Sponsor / Collaborator

Xiamen Zixu Pharmaceutical Technology Co., Ltd.

[+1]

CTR20254201

/ CompletedNot Applicable

秋水仙碱片人体生物等效性研究

[Translation] Colchicine tablets human bioequivalence study

主要目的：本试验旨在研究单次空腹和餐后口服厦门紫旭医药科技有限公司研制、广东安诺药业股份有限公司生产的秋水仙碱片（0.5 mg）的药代动力学特征；以TAKATA SEIYAKUCO.,Ltd生产的秋水仙碱片（Colchicine®，0.5 mg）为参比制剂，比较两制剂中药动学参数Cmax、AUC0-t、AUC0-∞，评价两制剂的人体生物等效性。

[Translation]

Main objective: This study aimed to investigate the pharmacokinetic characteristics of colchicine tablets (0.5 mg) developed by Xiamen Zixu Pharmaceutical Technology Co., Ltd. and manufactured by Guangdong Anno Pharmaceutical Co., Ltd., after a single fasting and postprandial oral administration. Using colchicine tablets (Colchicine®, 0.5 mg) manufactured by TAKATA SEIYAKU CO., Ltd. as a reference formulation, the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two formulations were compared to evaluate their bioequivalence in humans.

Start Date25 Nov 2025

Sponsor / Collaborator

Xiamen Zixu Pharmaceutical Technology Co., Ltd.

CTR20264003

/ Not yet recruitingPhase 3

评估维生素D口服溶液在维生素D缺乏试验参与者中的有效性和安全性的多中心、随机、双盲、安慰剂、平行对照的Ⅲ期临床试验

[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial evaluating the efficacy and safety of oral vitamin D solution in participants of a vitamin D deficiency trial.

主要目的：评价维生素D口服溶液在维生素D缺乏试验参与者中的有效性。次要目的： 1、以其他疗效终点评价维生素D口服溶液在维生素D缺乏试验参与者中的有效性。 2、评价维生素D 口服溶液在维生素D 缺乏试验参与者中的安全性。

[Translation]

Primary objective: To evaluate the efficacy of oral vitamin D solution in participants of a vitamin D deficiency trial. Secondary objectives: 1. To evaluate the efficacy of oral vitamin D solution in participants of a vitamin D deficiency trial using other efficacy endpoints. 2. To evaluate the safety of oral vitamin D solution in participants of a vitamin D deficiency trial.

Start Date-

Sponsor / Collaborator

Xiamen Zixu Pharmaceutical Technology Co., Ltd.

[+1]

100 Clinical Results associated with Xiamen Zixu Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Xiamen Zixu Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Xiamen Zixu Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Xiamen Zixu Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Nov 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3

1

Login to view more data